Quick Verdict: Hims is one of the largest telehealth platforms in the U.S. and has expanded aggressively into GLP-1 weight loss. It offers compounded semaglutide and tirzepatide starting at $199/month for injectables, with oral weight loss medication kits starting at $69/month. The app experience is among the best in telehealth, and the free initial assessment lowers the barrier to entry. On the downside, the lowest advertised prices require multi-month upfront commitments, subscription management and cancellation generate significant complaints, and Hims' push into compounded semaglutide pills has drawn legal threats from Novo Nordisk.

Overview

What Is Hims Weight Loss?

Hims (formally Hims & Hers Health) is a publicly traded telehealth company that started in men's health (hair loss, ED) and has expanded into weight loss, mental health, and other categories. The weight loss program offers GLP-1 receptor agonist medications through virtual consultations with licensed providers.

Hims provides access to both compounded GLP-1 injectables (semaglutide and tirzepatide) and oral medication kits that can include metformin, bupropion, topiramate, vitamin B12, and naltrexone. The platform also recently announced plans for a compounded oral semaglutide pill, though this has faced pushback from Novo Nordisk, the manufacturer of brand-name Ozempic and Wegovy.

The company's primary selling point is convenience: a clean sign-up process, transparent pricing pages, a well-built app, and medications shipped to your door.

Pricing in 2026

Hims' pricing structure uses tiered plans that offer lower monthly rates for longer commitments:

Injectable GLP-1 Plans

• 6-month plan: Starting at $199/month, paid in full upfront ($1,194 total)
• 12-month plan: Starting at $299/month, paid upfront in full
• Month-to-month: Higher per-month rate; varies by medication and dose

Oral Weight Loss Kits

• 10-month plan: Starting at $69/month, paid in full upfront
• Kits may include combinations of metformin, bupropion, topiramate, B12, and naltrexone

The advertised "starting at" prices are real but represent the lowest tier at the longest commitment. If you want month-to-month flexibility, expect to pay more per month. This is a common pricing strategy across subscription telehealth, but it means the number you see in ads may not reflect what you actually pay.

There are no membership fees beyond the cost of medication, and the initial assessment is free. Shipping is also free on all orders.

Medications Available

Compounded Semaglutide (Injectable)

The primary GLP-1 offering. Compounded semaglutide uses the same active ingredient as Ozempic and Wegovy but is prepared by compounding pharmacies. It is not FDA-approved. Hims partners with FDA-regulated 503A compounding pharmacies for production.

Compounded Tirzepatide (Injectable)

Available when supply allows. Tirzepatide is a dual GIP/GLP-1 agonist (same active ingredient as Mounjaro and Zepbound). Availability can fluctuate based on compounding pharmacy capacity and regulatory conditions.

Compounded Oral Semaglutide

In February 2026, Hims announced plans to offer a compounded semaglutide pill. Novo Nordisk has responded by threatening legal and regulatory action, calling it an "unapproved, inauthentic, and untested knockoff." The legal status and availability of this product may change.

Oral Weight Loss Kits

For patients who do not qualify for or prefer not to use GLP-1 injectables, Hims offers oral medication kits combining drugs like metformin (insulin sensitizer), bupropion (appetite suppressant), topiramate (appetite suppressant), naltrexone (craving reducer), and vitamin B12. These are FDA-approved drugs used off-label for weight loss.

Provider Quality and Consultations

Hims uses a broad provider network that includes MDs, nurse practitioners, and physician assistants. The initial consultation is an asynchronous health questionnaire rather than a live video call for many patients. A provider reviews your responses, medical history, and any relevant lab work before making a prescribing decision.

For straightforward cases, this works efficiently. You get a prescribing decision quickly without scheduling a video appointment. However, some patients report that the process can feel transactional, with limited opportunity to ask questions or discuss treatment options in depth.

Hims offers 24/7 messaging with a care team, which is a significant advantage over platforms like MEDVi that limit provider communication to business hours. Response quality can vary, with some patients noting that initial replies feel templated, though follow-up messages tend to be more personalized.

App and Digital Experience

This is where Hims genuinely excels. The Hims app is one of the best-designed telehealth interfaces available. It handles provider messaging, prescription tracking, shipment notifications, refill management, and treatment history in a single, clean interface.

The web experience is also well-built. Pricing pages are clear, the sign-up flow is streamlined, and information about medications and treatment plans is presented in accessible language. For patients who value a modern digital experience, Hims sets the standard in telehealth.

Subscription and Cancellation

This is the area that generates the most complaints about Hims. Key points:

• Cancellation deadline: You must cancel at least 48 hours before your next order date
• No refunds on processed orders: Once an order has been processed and shipped, Hims does not accept returns or offer refunds (medication cannot be returned)
• Subscription auto-renewal: Plans renew automatically. Some patients report that refills are processed earlier than expected, sometimes a month before the stated refill date
• Case-by-case refund exceptions: Hims may provide refunds at its sole discretion, but this is not guaranteed

BBB complaints about Hims frequently cite difficulties with cancellation and unauthorized subscription charges. This is a common pain point across subscription-based telehealth, but the volume of complaints suggests it is a persistent issue.

The Novo Nordisk Situation

Hims' move into compounded oral semaglutide has created a public conflict with Novo Nordisk, the pharmaceutical company that manufactures brand-name Ozempic and Wegovy. Novo Nordisk has criticized Hims for offering what it calls an "unapproved, inauthentic, and untested knockoff" and has signaled potential legal action.

For patients, this situation creates uncertainty. If legal or regulatory action limits Hims' ability to sell compounded semaglutide, it could affect product availability and pricing. Patients currently using Hims' compounded semaglutide products should be aware that the regulatory landscape could shift.

Pros

• Competitive pricing starting at $199/month for injectable GLP-1s
• Oral weight loss kits available from $69/month for non-GLP-1 options
• Best-in-class app and digital experience
• Free initial assessment and free shipping
• 24/7 provider messaging
• Large, established company (publicly traded on NYSE)
• Broad provider network and state availability
• Both semaglutide and tirzepatide offered

Cons

• Lowest advertised prices require multi-month upfront payments
• No refunds on processed or shipped medication orders
• Significant BBB complaints about subscription management and cancellation
• Compounded oral semaglutide faces legal challenges from Novo Nordisk
• Initial consultations can feel transactional (asynchronous questionnaire)
• Compounded medications are not FDA-approved
• Insurance generally not accepted for compounded medications
• Reports of refills processing earlier than expected

Who Is Hims Best For?

Hims is best for patients who want a streamlined digital experience, competitive pricing (especially with multi-month plans), and the convenience of a large, well-known telehealth platform. It is a strong choice for tech-comfortable patients who value app quality and 24/7 messaging.

Hims is less ideal for patients who want in-depth physician consultations, prefer month-to-month billing without upfront commitments, or are concerned about the regulatory uncertainty around compounded GLP-1 products.

Frequently Asked Questions

Is Hims weight loss legitimate?

Yes. Hims & Hers Health is a publicly traded company (NYSE: HIMS) with licensed providers and regulated pharmacy partnerships. It is one of the largest telehealth platforms in the U.S.

Does Hims offer brand-name Ozempic or Wegovy?

Hims has limited availability for branded GLP-1 medications. The primary offerings are compounded versions. If you need brand-name medications with insurance coverage, a traditional provider is likely a better path.

What is the cheapest Hims weight loss option?

Oral weight loss kits start at $69/month with a 10-month prepaid plan. Injectable GLP-1s start at $199/month with a 6-month prepaid plan. Month-to-month rates are higher.

Can I cancel Hims at any time?

You can cancel, but must do so at least 48 hours before your next order date. No refunds are issued for processed orders. Cancelling a prepaid multi-month plan does not typically result in a refund for unused months.

How does Hims compare to MEDVi?

Hims offers lower pricing, a better app, and 24/7 messaging. MEDVi offers physician-led consultations and metabolic lab panels. Hims is better for price and convenience; MEDVi is better for clinical depth. Both have documented billing and subscription complaints.

Want physician-supervised GLP-1 therapy without the subscription headaches? Form Blends offers telehealth weight loss programs with licensed physicians, transparent pricing, and no long-term commitments. Explore Form Blends.